)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
China Resources Sanjiu Medical & Pharmaceutical Co
China Resources Sanjiu Medical & Pharmaceutical Co (000999) investor relations material
China Resources Sanjiu Medical & Pharmaceutical Co Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary25 Apr, 2026
Executive summary
Revenue for Q1 2026 reached ¥8.13 billion, up 18.62% year-over-year, while net profit attributable to shareholders fell 15.29% to ¥1.08 billion.
Operating cash flow increased to ¥1.06 billion from ¥980 million year-over-year.
Significant increases in sales and R&D expenses impacted profitability.
Financial highlights
Revenue: ¥8.13 billion, up 18.62% year-over-year.
Net profit attributable to shareholders: ¥1.08 billion, down 15.29% year-over-year.
Basic and diluted EPS: ¥0.65, down from ¥0.77 year-over-year.
Gross margin and operating profit margin declined due to higher costs.
Cash and cash equivalents at period end: ¥3.20 billion, down 47.64% from prior year.
Outlook and guidance
Management highlighted increased R&D and sales investments as strategic for future growth.
No explicit forward guidance provided for the remainder of 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from China Resources Sanjiu Medical & Pharmaceutical Co
- 2025 revenue up 14.43%, net profit up 1.58%, with robust R&D and major acquisition.000999
Q4 202521 Mar 2026 - Revenue up 4.99% but net profit down 24.31% as Tasly acquisition reshapes business.000999Q2 202521 Jan 2026
- H1 2024 net profit rose 27.8% on 7.3% revenue growth, driven by CHC business strength.000999H1 202421 Jan 2026
- Revenue and net profit surged on strong CHC and prescription drug growth, with a 50% payout.000999Q4 202421 Jan 2026
- Revenue surged but profit declined as acquisition and investment costs rose sharply.000999Q3 202527 Oct 2025
- Net profit jumped 23.19% year-over-year, with strategic M&A and innovation fueling growth.000999Q3 202413 Jun 2025
- Revenue and profit declined, but asset growth and Tasly integration drive future potential.000999Q1 20256 Jun 2025
Next China Resources Sanjiu Medical & Pharmaceutical Co earnings date
Q2 202620 Aug, 2026
China Resources Sanjiu Medical & Pharmaceutical Co
Next China Resources Sanjiu Medical & Pharmaceutical Co earnings date
Q2 202620 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage